Press releases
- Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
- Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
- Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
- Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
- Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- Tandem Diabetes Care Announces Upcoming Conference Presentation
- Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
- Tandem Diabetes Care Announces Upcoming Conference Presentations
More ▼
Key statistics
On Monday, Tandem Diabetes Care Inc (0M0F:LSE) closed at 43.51, -19.44% below its 52-week high of 54.00, set on May 31, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | 43.51 |
Low | 43.51 |
Bid | -- |
Offer | -- |
Previous close | 43.51 |
Average volume | 1.09k |
---|---|
Shares outstanding | 64.59m |
Free float | 64.10m |
P/E (TTM) | -- |
Market cap | 2.95bn USD |
EPS (TTM) | -2.17 USD |
Data delayed at least 20 minutes, as of Jul 22 2024 19:00 BST.
More ▼